Before being diagnosed in July 1997, Chris was a strong 15 year-old boy, who played rugby, cricket and basketball. After twice battling back from the disease, achieving great GCSE results and starting a career in graphic design, the cancer finally took Chris after three years. The Chris Lucas Trust hopes to enable the rapid translation of new targeted therapies into the clinic so that other families don’t suffer the same fate.
Donations from the trust have already contributed to studies that found combining two separate molecularly-targeted therapies could block processes driving growth in rhabdomyosarcoma, a major cause of cancer death in children and young people.
Chris’ mum, Lynn, says: “The Chris Lucas Trust chose to support the ICR since we believe in their commitment to develop new drugs to help children and young adults suffering from cancer to live longer, and ultimately to find a cure for rhabdomyosarcoma. We recognised their expertise in childhood cancer when we first sought advice about funding research."
Learn more about our current research into treating rhabdomyosarcoma.
If you would like to get involved and support our childhood cancer research, please contact Nicola Shaw in the Development Team, call 020 8722 4227 or email Nicola.Shaw@icr.ac.uk.
Comments